Categories
News

Molnupiravir and Drug Development at Emory

Molnupiravir is currently being developed by Merck & Co. Inc. in collaboration with Ridgeback Biotherapeutics, which licensed the drug from DRIVE (founded by Emory chemist Dennis Liotta) in 2020. It could be the first oral antiviral medicine to treat COVID-19. Continue readingMolnupiravir and Drug Development at Emory

Categories
News

Andrew Mahoney receives ACS Medicinal Chemistry Predoctoral Fellowship

Graduate Scholar Andrew Mahoney has been awarded a 2021-2022 ACS Medicinal Chemistry Predoctoral Fellowship, an achievement he describes in quirky fashion in his brief autobiography.Continue readingAndrew Mahoney receives ACS Medicinal Chemistry Predoctoral Fellowship